Skip to main content
Log in

Differential Effects of Morning or Evening Dosing of Amlodipine on Circadian Blood Pressure and Heart Rate

  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Abstract

Objectives: To compare the effects of morning and evening dosing of amlodipine on both circadian blood pressure (BP) and heart rate (HR) in mild-to-moderate essential hypertension.

Design: A perspective, double-blind, randomized, crossover design with dose titration.

Patients and methods: Sixty-two patients recruited in the study were aged 21–77 years and had mild-to-moderate essential hypertension. At the end of a 2-week single-blind, placebo run-in period, eligible patients were randomly assigned to morning (7 AM) and evening (9 PM) amlodipine treatment. The initial dose was 5 mg. After 2 weeks of double-blind therapy, patients with a seated diastolic blood pressure ≥90 mm Hg had their doses titrated upward to 10 mg, while the other patients remained on their original 5 mg doses for another 4 weeks period, than crossover to the alternate dosing regimen for 6 additional weeks. The 24-h ambulatory monitoring was performed at baseline and at 6 and 12 weeks after randomization.

Results: 24-h diastolic BP load (11.0 ± 17.5% vs. 6.5 ± 9.1%, P < 0.05) and night-time BP load (28.5 ± 31.4%/17.7 ± 28.2% vs. 20.0 ± 27.9%/9.2 ± 17.8%, P < 0.05/0.05) were significantly greater with evening dosing compared with morning dosing. Nocturnal fall of BP was greater with morning dosing than with evening dosing (9.8 ± 6.7/7.4 ± 5.3 vs. 6.7 ± 6.6/5.4 ± 5.4 mm Hg, P < 0.01/0.05). Percentage of nocturnal BP fall was greater with morning dosing versus with evening dosing (7.9 ± 5.3%/9.6 ± 6.8% vs. 5.4 ± 7.0%/7.0 ± 6.9%, P < 0.01/0.05).

Conclusions: Morning administered amlodipine had a better effect on the circadian BP compared with evening administrated amlodipine in mild-to-moderate essential hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Prisant LM. Hypertension and chronotherapy: Shifting the treatment paradigm. Am J Hypertens 2001; 14: 277s-279s.

    Google Scholar 

  2. White WB. A chronotherapeutic approach to the management of hypertension. Am J Hypertens 1996; 10: 29s-32s.

    Google Scholar 

  3. Lemmer B. Differential effects of antihypertensive drugs on circadian rhythm in blood pressure from chronobiologic point of view. Blood Press Monitor 1996; 1: 161-169.

    Google Scholar 

  4. Palatini P,Racioppa A,Raule G,Zaninotto M,Penzo M,Pessina AC. Effect of timing of administration on the plasma ACE inhibitory activity and the antihypertensive effect of quinapril. Clin Pharmacol Ther 1992; 52: 378-383.

    Google Scholar 

  5. Pickering TG,Levenstein M,Walmsley P. Night-time dosing of doxazosin has peak effect on morning ambulatory blood pressure. Results of HALT study. Am J Hypertens 1994; 6: 844-847.

    Google Scholar 

  6. Whelton A,Miller WE,Dunne B Jr,Hait HI,Tresznewsky ON. Once-daily lisinopril compared with twice-daily captopril in the treatment of mild-to-moderate hypertension, assessment of office and ambulatory blood pressure. J Clin Pharmacol 1990; 30: 1074-1080.

    Google Scholar 

  7. Abernathy DA. Pharmacokinetics and pharmacodynamics of amlodipine. Cardiology 1992; 80(Suppl 1): 31-36.

    Google Scholar 

  8. White WB. Methods of blood pressure determination to assure antihypertensive agent: Are causal measurements enough? Clin Pharmacol Ther 1989; 45: 581-586.

    Google Scholar 

  9. Coats AJ,Conway J,Somers VK,Isea JE,Sleight P. Ambulatory blood pressure monitoring in the assessment of antihypertensive therapy. Cardiovasc Drugs Ther 1989; 3: 303-311.

    Google Scholar 

  10. White WB,Mansoor GA,Pickering TG, et al. Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate. Am J Hypertens 1999; 12: 806-814.

    Google Scholar 

  11. White WB. Circadian variation of blood pressure: Clinical relevance and implications for cardiovascular chronotherapeutics. Blood Press Monitor 1997; 2: 47-52.

    Google Scholar 

  12. Lemmer B,Portaluppi F. Chronopharmacology of cardiovascular disease. In: Redfern PH,Lemmer B, eds. Handbook of Experimental Pharmacology, Vol. 125, Berlin: Springer-Verlag, 1997: 251-297.

    Google Scholar 

  13. Morgan T,Anderson A,Jones E. The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night. J Hypertens 1997; 15: 205-211.

    Google Scholar 

  14. Witte K,Weisser K,Neubeck M, et al. Cardiovascular effects, pharmacokinetics and converting enzyme inhibition of enalapril after morning versus evening administration. Clin Pharmacol Ther 1993; 54: 177-186.

    Google Scholar 

  15. Greminger P,Suter PM,Holm D,Kobelt R,Vetter W. Morning versus evening administration of nifedipine gastrointestinal therapeutic system in the management of essential hypertension. Clin Invest 1994; 72: 864-869.

    Google Scholar 

  16. White WB,Mansoor GA,Tendler BE,Anwar VA. Nocturnal blood pressure epidemiology, determinant, and effects of antihypertensive therapy. Blood Press Monitor 1998; 3: 43-51.

    Google Scholar 

  17. Verdecchia P,Porcellati C,Schillaci G, et al. Ambulatory blood pressure: An independent predictor of prognosis in essential hypertension. Hypertension 1994; 24: 793-801.

    Google Scholar 

  18. Verdecchia P,Schillaci G,Guerrieri M, et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990; 81: 528-536.

    Google Scholar 

  19. Kuwajima I,Suzuki Y,Shimosawa T,Kanemaru A,Hoshino S,Kuramoto K. Diminished nocturnal decline in blood pressure in elderly hypertensive patients with left ventricular hypertrophy. Am Heart J 1992; 67: 1307-1311.

    Google Scholar 

  20. Rizzoni D,Muiesan ML,Montani G,Zulli R,Calebich S,Agabiti-Rosei E. Relationship between initial cardiovascular structural changes and daytime and night-time blood pressure monitoring. Am J Hypertens 1992; 5: 180-186.

    Google Scholar 

  21. Pierdomenico SD,Lapenna D,Guglielmi MD, et al. Arterial disease in dipper and nondipper hypertensive patients. Am J Hypertens 1997; 10: 511-518.

    Google Scholar 

  22. Ferrara AL,Pasanisi F,Crivaro M, et al. Cardiovascular abnormalities in never-treated hypertensives according to nondiper status. Am J Hypertens 1998; 11: 1352-1357.

    Google Scholar 

  23. Smolensky MH,Haus E. Circadian rhythms and clinical medicine with applications to hypertension. Am J Hypertens 2001; 14: 280s-290s.

    Google Scholar 

  24. Kario K,Matsuo T,Kobayashi H,Imiya M,Matsuo M,Shimada K. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly patients: Advanced silent cerebrovascular damage in extreme dippers. Hypertension 1996; 27: 130-135.

    Google Scholar 

  25. Watanabe N,Imai Y,Nagai K, et al. Nocturnal blood pressure and silent cerebrovascular lesions in elderly Japanese. Stroke 1996; 27: 1319-1327.

    Google Scholar 

  26. White WB,Dey HM,Schulman P. Assessment of the daily blood pressure load as a determinant of cardiac function in patients with mild-to-moderate hypertension. Am Heart J 1989; 118: 782-795.

    Google Scholar 

  27. Sorof JM,Cardwell G,Franco K,Portman RJ. Ambulatory blood pressure and left ventricular mass index in hypertensive children. Hypertension 2002; 39: 903-908.

    Google Scholar 

  28. Levy D,Garrison RJ,Savage DD,Kannel WB,Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-1566.

    Google Scholar 

  29. Casale PN,Devereux RB,Milner M, et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105: 173-178.

    Google Scholar 

  30. Pfeffer M. Clinical implications of left ventricular hypertrophy in systemic hypertension. Cardiovasc Rev Rep Jan 1991: 53-60.

  31. Schillaci G,Verdecchia P,Porcellati C,Cuccurullo O,Cosco C, andPerticone F. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension 2000; 35: 580-586.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Qiu, YG., Chen, JZ., Zhu, JH. et al. Differential Effects of Morning or Evening Dosing of Amlodipine on Circadian Blood Pressure and Heart Rate. Cardiovasc Drugs Ther 17, 335–341 (2003). https://doi.org/10.1023/A:1027347723347

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1027347723347

Navigation